BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36999652)

  • 1. Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC.
    You M; Gao Y; Fu J; Xie R; Zhu Z; Hong Z; Meng L; Du S; Liu J; Wang FS; Yang P; Chen L
    Hepatology; 2023 Sep; 78(3):943-958. PubMed ID: 36999652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
    Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma.
    Cheng Y; Gunasegaran B; Singh HD; Dutertre CA; Loh CY; Lim JQ; Crawford JC; Lee HK; Zhang X; Lee B; Becht E; Lim WJ; Yeong J; Chan CY; Chung A; Goh BKP; Chow PKH; Chan JKY; Ginhoux F; Tai D; Chen J; Lim SG; Zhai W; Choo SP; Newell EW
    Immunity; 2021 Aug; 54(8):1825-1840.e7. PubMed ID: 34270940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell landscape of immune cells during the progression from HBV infection to HBV cirrhosis and HBV-associated hepatocellular carcinoma.
    Bai Q; Li R; He X; Hong X; Yan Y; Zhao Z; Lin H; Tacke F; Engelmann C; Hu T
    Front Immunol; 2023; 14():1320414. PubMed ID: 38116005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B.
    Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P
    J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 marks the exhausted CD8
    Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
    Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients.
    Li FJ; Zhang Y; Jin GX; Yao L; Wu DQ
    Immunol Lett; 2013 Feb; 150(1-2):116-22. PubMed ID: 23261718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Zhang M; Zhao H; Gao H
    Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell analysis reveals HBV-specific PD-1
    Liu L; Liu J; Li P; Luo J; Qin R; Peng Q; Li B; Wei X; Wang T; Shi H; Wang MD; Li C; Fang W; Chen W; Xu X; Yang T; Yin W; Zeng X
    J Exp Clin Cancer Res; 2023 Jun; 42(1):152. PubMed ID: 37353792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.
    Sun R; Li J; Lin X; Yang Y; Liu B; Lan T; Xiao S; Deng A; Yin Z; Xu Y; Xiang Z; Wu B
    Front Immunol; 2023; 14():1079495. PubMed ID: 37077908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells.
    Noyes D; Bag A; Oseni S; Semidey-Hurtado J; Cen L; Sarnaik AA; Sondak VK; Adeegbe D
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD1
    Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
    J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.
    Yang F; Zheng X; Koh S; Lu J; Cheng J; Li P; Du C; Chen Y; Chen X; Yang L; Chen W; Wong RW; Wai LE; Wang T; Zhang Q; Chen W
    Hepatol Int; 2023 Aug; 17(4):850-859. PubMed ID: 37067675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
    Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
    Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
    Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
    Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD8
    Li J; Chen H; Bai L; Tang H
    BMC Cancer; 2024 Jan; 24(1):53. PubMed ID: 38200408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.